Search results for "Prenatal diagnosis."

showing 10 items of 112 documents

Fraser syndrome: epidemiological study in a European population

2013

Fraser syndrome is a rare autosomal recessive disorder characterized by cryptophthalmos, cutaneous syndactyly, laryngeal, and urogenital malformations. We present a population-based epidemiological study using data provided by the European Surveillance of Congenital Anomalies (EUROCAT) network of birth defect registries. Between January 1990 and December 2008, we identified 26 cases of Fraser syndrome in the monitored population of 12, 886, 464 births (minimal estimated prevalence of 0.20 per 100, 000 or 1:495, 633 births). Most cases (18/26 ; 69%) were registered in the western part of Europe, where the mean prevalence is 1 in 230, 695 births, compared to the prevalence 1 in 1, 091, 175 fo…

CryptophthalmosMalemedicine.medical_specialtyEpidemiologyAnorectal anomaliesPopulationprevalencePrevalencePrenatal diagnosisinduced abortionCongenital abnormalitiesPregnancyInduced abortionGeneticsPrevalenceMedicineHumansCRITERIASyndactylyRegistriesPRENATAL-DIAGNOSISeducationFraser syndromeRenal agenesisGenetics (clinical)education.field_of_studycongenital abnormalitiesprenatal diagnosisFraser syndrome; epidemiology; prevalence; congenital abnormalities; prenatal diagnosis; induced abortionbusiness.industryObstetricsMUTATIONSInfant Newbornmedicine.diseaseBilateral Renal AgenesisEuropeEpidemiologic StudiesCRYPTOPHTHALMOSFemaleepidemiologyFraser syndromebusiness
researchProduct

The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis

2019

BackgroundCongenital Toxoplasmosis (CT) can have severe consequences. France, Austria, and Slovenia have prenatal screening programs whereas some other countries are considering universal screening to reduce congenital transmission and severity of infection in children. The efficiency of such programs is debated increasingly as seroprevalence among pregnant women and incidence of congenital toxoplasmosis show a steady decrease. In addition, uncertainty remains regarding the effectiveness of pre- and postnatal treatments.MethodTo identify cost-effective strategies, prenatal and neonatal screenings were compared using a decision-analytic model based on French guidelines and current knowledge …

Decision AnalysisEconomicsMaternal HealthCost-Benefit AnalysisSloveniaSocial SciencesPediatricsToxoplasmosis CongenitalPregnancy[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesPrenatal DiagnosisMedicine and Health Sciences[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology[SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseasesQRObstetrics and Gynecology[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemFetal deathAustria[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesMedicineEngineering and TechnologyFemaleFranceManagement EngineeringToxoplasmosis[SDV.MP.PAR] Life Sciences [q-bio]/Microbiology and Parasitology/ParasitologyResearch ArticleScienceDecision treesClinical Decision-MakingResearch and Analysis MethodsPediatric infectionsNeonatal Screening[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemParasitic DiseasesHumans[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/ParasitologyProtozoan InfectionsCost-effectiveness analysisInfant NewbornBiology and Life SciencesNeonatesModels Theoretical[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyEconomic AnalysisPregnancy ComplicationsBirthWomen's Health[SDV.MP.BAC] Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyDevelopmental Biology
researchProduct

Three-dimensional visualization of the human embryo: a potential revolution in prenatal diagnosis

1996

Diagnostic Imagingmedicine.medical_specialtyPregnancyRadiological and Ultrasound Technologybusiness.industryObstetricsObstetrics and GynecologyGestational ageGestational AgePrenatal diagnosisEmbryoGeneral MedicineEmbryo Mammalianmedicine.diseaseUltrasonography PrenatalReproductive MedicinePregnancyThree dimensional visualizationImage Processing Computer-AssistedMedical imagingHumansMedicineFemaleRadiology Nuclear Medicine and imagingbusinessUltrasound in Obstetrics and Gynecology
researchProduct

First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction

2005

BACKGROUND: Serum biochemical markers [free betahCG (fbetahCG); pregnancy-associated plasma protein-A (PAPP-A)] used in first trimester Down's syndrome screening have not been fully investigated in pregnancies achieved by assisted reproduction techniques. We present data on pregnancies conceived by all types of assisted reproduction techniques, including pregnancies following ovum donation (OD) and a large sample by ICSI. METHODS: First trimester Down's syndrome screening was performed in 1054 normal singleton pregnancies: natural conception (n = 498), ovulation induction (OS, n = 97), IVF (n = 47), ICSI (n = 222) and OD (n = 190). RESULTS: No differences in maternal levels of fbetahCG and …

Down syndromemedicine.medical_specialtyReproductive Techniques AssistedPregnancy-associated plasma protein Amedicine.medical_treatmentPrenatal diagnosisBiologyPreimplantation genetic diagnosisEmbryo cryopreservationPregnancyPrenatal DiagnosismedicineHumansChorionic Gonadotropin beta Subunit HumanFalse Positive ReactionsGynecologyPregnancyurogenital systemObstetricsRehabilitationReproducibility of ResultsObstetrics and GynecologyGestational agemedicine.diseasePregnancy Trimester FirstReproductive MedicineFemaleOvulation inductionDown SyndromeBiomarkersHuman Reproduction
researchProduct

Very early prenatal diagnosis of Cockayne’s syndrome by coelocentesis

2022

Cockayne’s syndrome (CS) is a rare autosomal recessive multisystem disease characterised by early severe progression of symptoms. This study reports the feasibility of earlier prenatal diagnosis of CS by coelocentesis at 8 weeks of gestation respect to amniocentesis or villocentesis. Three couples at risk for CS asked to perform prenatal diagnosis by coelocentesis. Coelomic fluid was aspired from coelomic cavity in four singleton pregnancy at 8 weeks of gestation and 40 foetal cells were recovered by micromanipulator. Maternal DNA contamination was evaluated by quantitative fluorescent PCR (QF-PCR) and target regions of foetal DNA containing parental mutations of ERCC6 gene were amplified a…

ERCC6Sex FactorsPregnancyPlacentaPrenatal diagnosisHumansObstetrics and GynecologyFemaleCelocentesis Cockayne’s syndrome Coelomic fluid CSBDNAPolymerase Chain ReactionFoetal cell
researchProduct

Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis

2006

Familial haemophagocytic lymphohistiocytosis (FHL) is a genetically heterogeneous disorder characterised by constitutive defects in cellular cytotoxicity resulting in fever, hepatosplenomegaly and cytopenia, and the outcome is fatal unless treated by chemoimmunotherapy followed by haematopoietic stem‐cell transplantation. Since 1999, mutations in the perforin gene giving rise to this disease have been identified; however, these account only for 40% of cases. Lack of a genetic marker hampers the diagnosis, suitability for transplantation, selection of familial donors, identification of carriers, genetic counselling and prenatal diagnosis. Mutations in the Munc13–4 gene have recently been des…

EXPRESSIONMalePRF1AdolescentFHLBlotting WesternDNA Mutational AnalysisHepatosplenomegalyDONORSPrenatal diagnosisBiologymedicine.disease_causeLymphohistiocytosis HemophagocyticGeneticsmedicinePERFORIN GENE-MUTATIONSHumansUNC13DChildGenetics (clinical)Family HealthSPECTRUMHemophagocytic lymphohistiocytosisMutationCytopeniaMicroscopy ConfocalIDENTIFICATIONGenetic heterogeneityInfant NewbornCYTOTOXIC T-LYMPHOCYTESInfantMembrane Proteinsmedicine.diseaseBONE-MARROW-TRANSPLANTATIONTransplantationMicroscopy ElectronChild PreschoolMutationImmunologyFemalemedicine.symptomLetter to JMGT-Lymphocytes CytotoxicJournal of Medical Genetics
researchProduct

Fetal presentation of Morquio disease type A.

1992

A fetus with mucopolysaccharidosis type IV A (Morquio type A) is described. The family had one affected child exhibiting symptoms of classical Morquio A disease, and late in the subsequent pregnancy prenatal diagnosis was requested. At 23 weeks' gestation, moderate ascites was detected by detailed ultrasound scan and keratan sulphate was found in the amniotic fluid. The pregnancy was terminated by prostaglandin induction and the diagnosis of mucopolysaccharidosis type IV A was confirmed by demonstration of a deficiency of N-acetylgalactosamine-6-sulphate (GalNac-6-S) sulphatase in cultured amniotic cells and in post-mortem fibroblast cultures. The activities of beta-galactosidase and arylsu…

ElectrophoresisMalemedicine.medical_specialtyAmniotic fluidPlacentaMucopolysaccharidosis type IVNeuraminidasePrenatal diagnosisConsanguinityPregnancyHydrops fetalisInternal medicineLysosomal storage diseaseMedicineHumansChildGenetics (clinical)GlycosaminoglycansUltrasonographyFetusPregnancybusiness.industryObstetrics and GynecologyAscitesMucopolysaccharidosis IVmedicine.diseaseAmniotic Fluidbeta-GalactosidaseEndocrinologyKeratan SulfatePregnancy Trimester SecondMucopolysaccharidosis IVAmniocentesisFemaleSulfatasesbusinessPrenatal diagnosis
researchProduct

Paper 6: EUROCAT member registries: organization and activities.

2011

BACKGROUND: EUROCAT is a network of population-based congenital anomaly registries providing standardized epidemiologic information on congenital anomalies in Europe. There are three types of EUROCAT membership: full, associate, or affiliate. Full member registries send individual records of all congenital anomalies covered by their region. Associate members transmit aggregate case counts for each EUROCAT anomaly subgroup by year and by type of birth. This article describes the organization and activities of each of the current 29 full member and 6 associate member registries of EUROCAT. METHODS: Each registry description provides information on the history and funding of the registry, popu…

EmbryologyPediatricsDatabases FactualENGLANDMultiple congenital anomalyAge limit0302 clinical medicinePregnancyPrenatal DiagnosisPrevalenceConfidentiality030212 general & internal medicineRegistriesRISK0303 health scienceseducation.field_of_studyFetal death030305 genetics & hereditycongenital anomaly registriesGeneral MedicineorganizationStillbirthascertainment3. Good healthComputer algorithmEuropeCONGENITAL-ANOMALIESPrenatal screeningEvaluation Studies as TopicPopulation SurveillanceCommittee MembershipFemaleMedical emergencymedicine.medical_specialtyPopulationPopulation basedCongenital Abnormalities03 medical and health sciencesmedicineHumanseducationFetal DeathInternetbusiness.industryRENACAbortion InducedEstados de Saúde e de Doençamedicine.diseasepopulation-basedcongenital anomalies ; Europe ; multiple congenital anomaly ; computer algorithm ; classification ; surveillance ; etiologyPediatrics Perinatology and Child HealthbusinessDevelopmental BiologyBirth defects research. Part A, Clinical and molecular teratology
researchProduct

Sonographic Prognostic Factors in Prenatal Diagnosis of SCT

2003

<i>Objective:</i> A subset of fetuses with sacrococcygeal teratomas (SCT) develops hydrops caused by high-output heart failure. Identification of fetuses at risk for hydrops is important because surgical intervention may reverse the pathophysiology of the disease. The aim of this study was to evaluate sonographic prognostic factors regarding tumor morphology and vascularity associated with the development of hydrops in utero. <i>Methods:</i> Over a 10-year period, we identified 7 fetuses with SCT diagnosed antenatally and managed at the University of Mainz. We retrospectively reviewed the charts of mothers and infants and recorded data on prenatal diagnosis, tumor si…

Embryologymedicine.medical_specialtyPrenatal diagnosisUltrasonography PrenatalDiagnosis DifferentialPregnancyHydrops fetalisHumansMedicineRadiology Nuclear Medicine and imagingRetrospective StudiesFetusPregnancySacrococcygeal Regionbusiness.industryVaginal deliveryObstetricsInfant NewbornTeratomaObstetrics and GynecologyGestational ageGeneral MedicinePrognosismedicine.diseaseembryonic structuresPediatrics Perinatology and Child HealthFemaleTeratomabusinessSacrococcygeal teratomaFetal Diagnosis and Therapy
researchProduct

Prenatal Ultrastructural Diagnosis in the Neuronal ceroid-lipofuscinoses

1994

Summary The neuronal ceroid-lipofuscinose (NCL) are autosomal-recessive disorders in childhood of unknown enzymatic origin. They can be recognized by the presence of abnormal lipopigments identified by electron microscopy. Based on the study of circulating lymphocytes, individual clinical subtypes of NCL can be correlated. Prenatal diagnosis of NCL with the electron microscope is now feasible for the infantile (Finnish) from (INCL) and late-infantile form (LINCL). INCL-specific granular lipopigments are present in endothelial cells of biopsied chorion stroma vessels of homozygously affected fetuses. In LINCL, disease-typical curvilinear bodies can be identified in uncultured amniotic fluid …

FetusPathologymedicine.medical_specialtyAmniotic fluid cellsCurvilinear bodiesPrenatal diagnosisChorionCell BiologyBiologyAmniotic FluidPathology and Forensic MedicineMicroscopy ElectronStromaNeuronal Ceroid-LipofuscinosesPregnancyPrenatal DiagnosisUltrastructuremedicineHumansFemaleElectron microscopicNeuronal Ceroid-LipofuscinosesPathology - Research and Practice
researchProduct